ATF4 and intracerebral hemorrhage: There are studies demonstrating that neuroprotection exerted by adaptaquin in vivo is not HIF dependent [33]. Protection from oxidative death in vitro or from intracerebral hemorrhage in vivo by adaptaquin was associated with suppression of the activity of the pro-death factor ATF4 rather than the activation of an HIF-dependent prosurvival pathway [20].